User:Crusher123/Kalos Therapeutics

Kalos Therapeutics is a biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer.

Kalos has been covered by ABC News on Good Morning America, and profiled in Business Week. The company aggressively targets diseases caused by an abnormally high growth rate of cells (hyper proliferation), and is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.